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Abstract 
The word ‘compliance’ comes from the Latin word complire, meaning to fill up and hence to complete an action, transaction, or process 
and to fulfil a promise. In the Oxford English Dictionary, the relevant definition is ‘The acting in accordance with, or the yielding to a 
desire, request, condition, direction, etc.; a consenting to act in conformity with; an acceding to; practical assent”. Compliance with 
therapy is simply patients understanding of medication, motivation toward having this medication is a prescribed manner with the 
belief that the prescriber and prescribed medicine will be beneficial for his well-being. Although this is often the case, in a number of 
situations, the physician and pharmacist have not provided the patient with adequate instructions or have not presented the 
instructions in such a manner that the patient understands them. Nothing should be taken for granted regarding the patient’s 
understanding of how to use medication, and appropriate steps must be taken to provide patients with the information and counseling 
necessary to use their medications as effectively and as safely as possible. 20% to 30% of new prescriptions are never filled at the 
pharmacy. Medication is not taken as prescribed 50% of the time. For patients prescribed medications for chronic diseases, after six 
months, the majority take less medication than prescribed or stop the medication altogether. There are both federal and state laws 
that make using or sharing prescription drugs illegal. If someone take a pill that was prescribed to someone else or give that pill to 
another person, not only is it against the law, it's extremely dangerous. 
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Introduction 
According to the WHO, lack of adherence to medical treatment 
regimen gives rise to major clinical problems in patients, mostly 
with chronic illness. Rates of nonadherence with any 
medication treatment varies from 15% to 93%, with an average 
estimated rate of 50% worldwide. “Drugs don’t work if people 
don’t take them.” This observation made by former Surgeon 
General C Everett Koop in his keynote address at a symposium 
on Improving Medication Compliance, provides a clear 
statement of one of the consequences of noncompliance. In 
many cases noncompliance results in underuse of a drug, 
thereby depriving the patient of the anticipated therapeutic 
benefits and possibly resulting in a progressive Medication 
nonadherence for patients with chronic diseases is extremely 
common, affecting as many as 40% to 50% of patients who are 
prescribed medications for management of chronic conditions 
such as diabetes or hypertension. This nonadherence to 
prescribed treatment is thought to cause at least 100,000 
preventable deaths and $100 billion in preventable medical 
costs per year. Despite this, the medical profession largely  
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ignores medication nonadherence or sees it as a patient 
problem and not a physician or health system problem. A 
recent BMJ study shows annual costings of medication non-
adherence range from USD 100 to USD 290 billion in USA, 
€1.25 billion in Europe and approximately $A7 billion in 
Australia. Along with staggering economic losses, patient 
compliance also presents a major hurdle to patient health. For 
instance, compliance rates below 90% for HIV patients can 
cause viral replication and disease progression while for 
diabetics, proper compliance is essential in preventing 
hypertension and myocardial infarction. Adherence consists of 
three essential factors:  
 
A. Patient: Takes treatment decision process by their 
own, based on individual literacy and feedback from 
others, mostly non-professionals. 
 
B. Provider: Prescribe drug/non-drug treatments and 
face communication barriers 
 
C. Healthcare system: Access to care, time allotted for 
technical support 
 
 
 
Commentary PHARMACY PRACTICE 
 
http://z.umn.edu/INNOVATIONS                        2019, Vol. 10, No. 1, Article 3                      INNOVATIONS in pharmacy 
                                                                             DOI: https://doi.org/10.24926/iip.v10i1.1621 
2 
 
1.1. Types of patients: Based on the acceptance of diagnosis 
and treatment initiation, patients are categorized into four 
types: 
• Non-compliers: Those who do not accept both 
diagnosis and need treatment. 
• Partial compliers: Those who accept diagnosis and 
treatment but fulfill the recommended actions 
partially, occasionally and sometimes never. 
• Over compliers: These patients are rare. 
• Adequate compliers: Those who follow treatment 
advise adequately to improve or control their disorder 
(Manmohan et.al., 2012) 
 
1.2. Types of Medication Taking Behavior 
a. Compliance: Understanding providers instructions 
consciously and behavior coincides with medical & 
health advice, also applicable for other situations 
such as medical device use, self-care, self-directed 
exercises, or therapy sessions. Given a specific 
prescription, compliance can be further classified 
with respect to the potential ways a patient can 
deviate from a provider’s instructions. Primary 
compliance is defined as a patient’s fidelity of filling 
and refilling prescriptions. Secondary compliance 
refers to whether a patient actually consumes their 
medication.  
b. Adherence: WHO defines adherence as “The extent 
to which a person’s behavior, corresponds with 
agreed recommendations from a health care 
professional”. Adherence is broadly related to 
instructions concerning medicine intake, use of 
medical device, diet, exercise, life style changes, rest 
and return for scheduled appointments. 
c. Concordance: Consultative and consensual therapy 
partnership between the consumer and their doctor. 
Concordance is when a patient and clinician make 
decisions together about treatment. 
d. Persistence: A person’s ability to continue medical 
advice that may range from few days to life-long 
(Fraser, 2010 and Klobusicky et.al, 2017). 
 
1.3. Dimensions of Patient Medication Adherence 
Adherence is a multidimensional phenomenon determined by 
the interaction of five sets of factors-- termed "dimensions" by 
the WHO. These dimensions are:   
 Social/economic: It is a social support from 
acquaintance or caregivers to assist with medication 
regimens have better adherence to treatment. People 
with poor healthcare access, unstable living, financial 
lack, high medication costs are of decreased 
adherence rates.   
 Provider-patient/health care system: A good provider 
patient relationship, reinforce and motivates patients 
to adhere treatment regimens. Conversely, Poor or 
lack of communication contributes nonadherence, 
especially in older adults with cognitive dysfunction. 
 Condition-related: In chronic illness, where drug 
administration is lengthy, adherence significantly 
declines over time, its human nature. Mostly happens 
when symptoms are not prominent, diminished or 
absent. 
 Therapy-related: The complexity of the medication 
regimen, numbers of medications and their daily 
doses, long-term therapy recommended that 
interferes patient’s lifestyle or the untoward effects 
that discomfort patients results non-adherence. 
 Patient factors: Physical impairments and cognitive 
dysfunctions may increase the risk for nonadherence 
in older adults. Poor knowledge about the disease and 
the reasons why medication is needed, lack of 
motivation, low self-efficacy, and substance abuse are 
associated with poor medication adherence (Fatima 
et.al, 2018, Wu et.al, 2008, Sabate, 2003).  
 
1.4.  Medication Non-adherence: An Eccentric East West 
Analogy 
Medication nonadherence remains a substantial public health 
problem. Causes of medication non-adherence are complex 
and include psychosocial (e.g., alcohol use, depression, stigma), 
structural (eg, distance from clinics, medication costs), therapy-
related (e.g., toxicities) and health system–related barriers 
(e.g., lack of counselling, poor user-experience with the health 
system) (Subbaraman et.al, 2018). Studies have found that 
patients’ beliefs about medicines and their perception of their 
illness contribute towards poor adherence (Kumar et.al, 2016). 
Worldwide, between 25% and 50% of patients do not take their 
medications as recommended. In the USA, suboptimal 
adherence has been associated with 125,000 deaths, 10% of 
hospitalizations, and costs 300 billion USD annually (Zullig et.al, 
2018). The economic impact was also in PubMed and Scopus in 
September 2017, which shows an increase in total healthcare 
cost (>80%), pharmacy costs (70%), inpatient and outpatient 
costs (50%), emergency department visit and medication costs 
(<30%), and hospitalization costs (<20%) (Cutler et.al, 2018). 
Nearly 70% of all medication-related hospital admissions are 
due to medication non-adherence alone (Kuo et.al, 2016). 
Across South Asia, overall hypertension prevalence is estimated 
to be 27%. Prospective Urban Rural Epidemiology study has 
shown more than 50% are unaware of it and up to 80% of 
hypertensive patients have low adherence to medication 
(Naheed et.al, 2018). Uncontrolled BP was found more than 
50% in Bangladesh, 70% in Pakistan and almost 60% in Sri Lanka 
(Jafar et.al, 2018). American Diabetes Association and the 
European Association for the Study of Diabetes guidelines in 10 
developing countries from Africa (Egypt, South Africa), Middle 
East (Israel, Saudi Arabia, United Arab Emirates, Iran and 
Lebanon) and South Asia (Bangladesh, India and Pakistan) 
shows more than 25% and around 70% patients did not have 
any follow-up visit by a diabetologist or a GP, respectively. More 
than 35% patients did not receive any diabetes education (Al-
Mansari et.al, 2018). In a study conducted among people with 
diabetes, only 30% were compliant with drug regimens and the 
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non-compliance was higher among the lower socioeconomic 
groups (Shrivastava et.al, 2013). 
 
1.5. Non-patient Factors associated with Non-adherence 
• The nature of patient illness  
• Therapeutic regime  
• Treatment duration 
• Frequency of drug administration 
• Adverse events 
• Taste of medication  
 
2. Patient Non-Compliance 
Non-compliance with drug treatment is widespread. When 
patients are given medication by their doctors, nearly half do 
not take the drug or do not take it as prescribed, and most will 
stop the treatment as soon as they are feeling better. A major 
problem in identifying the non-compliant patient is the 
unreliability of many of the measures used for assessing 
compliance. There are few social and demographic 
characteristics associated with non-compliance. The type of 
disease, also, generally has little influence on the level of 
compliance. Psychological factors such as the patients' levels of 
anxiety, motivation to recover, attitudes towards their illness, 
the drug and the doctor, as well as the attitudes and beliefs of 
significant others in their environment do influence the 
patients' levels of compliance (Evans et.al., 1983). One of the 
more compelling rationales offered for expanding drug 
coverage is that affordability problems have clinical as well as 
economic consequences; that is, patients who have difficulty 
paying for medications are less likely to take them and can 
suffer adverse health effects as a result of noncompliance 
(Kennedy et.al., 2002). 
 
2.1. Types of Non-compliance The situations most commonly 
associated with noncompliance with drug therapy include 
following situations: 
a) Some patients for whom medication has been prescribed 
do not even take their prescriptions to a pharmacy, and 
some others who do take their prescriptions to a pharmacy 
fail to pick them up when they are completed.  
b) The omission of doses is one of the most common types of 
noncompliance and occurs when a medication is to be 
administered at frequent intervals and/or for an extended 
period of time.  
c) Errors of dosage include situations when incorrect amount 
of an individual dose or frequency of administration occurs 
d) Examples of the incorrect administration of medication 
include not using the proper technique in using metered-
dose inhalers and, in some cases, giving medication by the 
wrong route of administration. 
e) Errors in the time of administration of the drug may include 
situations in which medication is administered in an 
inappropriate relationship to meals. Certain drugs—e.g., 
tetracycline, alendronate (Fosamax)—should be 
administered apart from meals to achieve optimal 
absorption. The time of day at which a drug is administered 
also may be important in the use of some medications; e.g., 
diuretics are best administered in the morning. 
f) The premature discontinuation of treatment occurs 
commonly with the use of antibiotics as well as 
medications used in the treatment of chronic disorders 
such as hypertension (Hussar, 2006).  
 
2.2. Reasons of Non-compliance in elderly patients 
Currently the aging population is rapidly increasing, particularly 
in developing regions of the world, due to longer expectancy of 
life, better healthcare facilities and greater awareness about 
healthy lifestyle. Today, in developed countries, more than 75% 
die after the age of 75 years (Lunenfeld et.al, 2013).  Because of 
the progressively increasing geriatric population requiring 
special care, there is a growing global concern to improve the 
health care delivery systems, particularly against chronic and 
recurrent illnesses that occur more commonly during later life 
such as: diabetes mellitus, hypertension, IHD, arthritic 
disorders, neurodegenerative disorders, psychiatric illnesses, 
gastrointestinal disorders, ocular disorders, genitourinary 
disorders, respiratory disorders etc., which may require chronic 
medication with multiple drugs. Because of the chronic nature 
of the disease, the need for multiple drug therapy with complex 
medication regime, increasing cost of therapy, adverse effects, 
drug interactions, forgetfulness, lack of familial and social 
support and care, elderly patients may not be fully compliant to 
long term medications. In general, only 50% of general 
population has been estimated to adhere to their medications, 
and this may range from 47 to 100% in elderly. Poor compliance 
among older persons is a public health concern, as it accounts 
for adverse outcomes, medication wastage with increased cost 
of healthcare, and substantial worsening of the disease with 
increased disability or death (Shruthi et.al, 2016). However, 
Notable Reasons behind elderly non-compliance issues are:  
• Adverse effects 
• Increased, or decreased sensitivity to drugs 
• Frequent change of prescriptions (prescription 
cascade) 
• Living alone 
• Lack of social support system 
• Difficulty in opening the medication container that has 
flip off type of lid 
• Going to pharmacist/chemist due to physical problems 
like (osteoarthritis) 
• Cognitive impairment 
• Impaired mobility or dexterity 
• Swallowing problems 
• Financial issues like, Low income and high cost of 
medications 
• Everyday inconvenience in carrying and taking of 
medicines (Jin et.al., 2016) 
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2.3. Consequences of Non-compliance 
Physicians frequently do not effectively communicate to their 
patients about the basic information of treatment plans. 
Patients may be left with concerns about adverse effects and 
with lack of comprehension of disease and treatment that 
adversely affect their adherence. Framing the problem of poor 
adherence on patients’ fear of side effects or lack of 
understanding does not clearly emphasize the physician’s 
responsibility to appropriately address these concerns. The 
same hurdle can be reformulated as a problem of physicians’ 
inadequate, ineffective communication to patients of critical 
information. This reformulation demonstrates that physicians 
have a responsibility to minimize barriers to non-compliance by 
changing that which physicians have control over patients’ own 
behavior (Devine et.al, 2018). Notable non-compliance results 
are:  
a) Underuse of a drug, deprives the patient of the anticipated 
therapeutic benefits and possibly resulting in a progressive 
worsening or other complications of the condition being 
treated e.g. underutilization and nonadherence of warfarin 
among nonvalvular AF patients is both prevalent and costly 
(Casciano et.al., 2013). The statins significantly reduce 
morbidity and mortality in patients with CHD and in 
patients with hyperlipidemia, when they are used on a 
continuing basis (Rosuvastatin, up to 55% reduction in LDL, 
up to 20% lowering in triglycerides, and up to 10% increase 
in HDL) (Lardizabal et.al., 2010). Underuse of 
antihypertensive medications may be associated with 
hospitalization that could have been prevented if patients 
had complied with their treatment regimens.  
b) Overuse of a drug, mostly increases risk of ADR e.g. MOH 
reported with antimigraine drugs (ergots and triptans) 
including nausea, dizziness and coronary vasoconstriction 
(González-Hernández et.al, 2018). AIM survey noted that 
25% of patients rely on SABA monotherapy to manage their 
persistent asthma, many of whom use albuterol daily. 
MEPS noted that 15% of patients with asthma use more 
than 1 canister of albuterol per month. These patients had 
twice the risk of an asthma-related emergency department 
visit or hospitalization as compared to those who filled 
albuterol less frequently (Gerald et.al., 2015) 
 
3. Factors Associated with Non-compliance 
3.1. Disease: Antipsychotic medication reduces the severity of 
serious mental illness (SMI), nonadherence to the 
treatment of SMI increases the risk of relapse and 
hospitalization. Poor insight was identified as a reason for 
nonadherence in more than 50% of studies, followed by a 
negative attitude toward medication in 30% and cognitive 
impairments in nearly 15% (Velligan et.al, 2017). Patients 
with chronic disorders, particularly conditions such as 
hypertension (45% in Bengaluru, 50% in Pakistan and 60% 
in Mumbai) (Shah et.al., 2018) and hypercholesterolemia 
(60% in Kuwait) (Al-Foraih et.al, 2016), which often are not 
associated with symptoms are also more likely to be 
noncompliers. Patients understandably tend to become 
discouraged with extended therapeutic programs that do 
not produce cures of the conditions. 
 
3.2. Therapeutic Regimen 
a) Multiple Drug Therapy: Even when specific dosage 
instructions for the medications are provided, problems 
still can occur with multiple drugs. The similarity of 
appearance (e.g., size, color, or shape) of certain drugs may 
contribute to the confusion that can exist in the use of 
multiple drugs. The prevalence of non-adherence in elderly 
patients receiving polypharmacy ranged from 6% to 55%. 
Medication adherence was negatively associated with 
large caregiver burden, impaired hearing, poor cognition 
and greater number of drugs in elderly patients (Zelko et.al, 
2016).  
b) Frequency of Administration: Patients with chronic 
diseases appear to be more adherent with once-daily 
compared with more frequently scheduled medication 
regimens (Coleman et.al, 2012). ATSP was shown to be an 
effective strategy to improve medication adherence in 
cardiovascular patients (Jung et.al., 2017 and Shroufi et.al., 
2010) 
c) Duration of Therapy: The potential for noncompliance is 
greater when the treatment period is long. In a free 
retroviral therapy by CDC in China with HIV patients 
(duration 17.7 month) revealed non-adherence with 
progression of time. Therefore, high priority must be given 
to the assessment of adherence behavior as well as any 
necessary intervention for non-adherence during the early 
stages of treatment (Yu et.al., 2018) 
d) Adverse Events: Side effects can be a problem with blood 
pressure medications. Some people find that the 
treatment may make them feel worse than the disease, 
which usually has no symptoms (WebMD, 2017). The 
adverse events (e.g., nausea, vomiting, hair loss) 
associated with the use of many antineoplastic drugs are 
sufficiently distressing to a number of patients with cancer 
that they do not take their medication in the manner 
intended. The ability of certain drugs to cause sexual 
dysfunction is a reason for noncompliance by some 
patients, with the antipsychotic agents, antidepressants 
(TCAs 30%, MAO inhibitors 40%, SSRIs 60%–70%, 
venlafaxine 70% and duloxetine 46% in Western 
populations) (Lahon et.al., 2011) and antihypertensive 
agents (thiazide-class diuretics, β-blockers, and centrally 
acting sympathoplegics reported) being implicated most 
frequently (Al-Khaja et.al., 2016). 
e) Patients may be asymptomatic or Symptoms subside: 
Situations frequently occur in which patients do not 
complete a full course of antibiotic therapy once they feel 
that the infection has been controlled. Many studies have 
shown that two-thirds of hypertensive patients do not 
achieve control. Poor adherence is probably more common 
in chronic conditions that are relatively asymptomatic for 
example hypertension (Chia, 2008). 
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f) Cost of Medication: The financial burden of medications 
may lead individuals to adopt various rationing or 
restrictive behaviors, such as CRNA to medications. The 
prevalence of CRNA varies between 4% and 36% in Canada 
(Gupta et.al, 2018). Estimated prevalence of CRNA among 
all older adults varied from <3% in the France, Norway, 
Sweden, Switzerland and the UK to 16.8% in the USA. Older 
adults in the USA were approximately six times more likely 
to report CRNA than older adults in the UK (Morgan et.al, 
2017). 
g) Administration of Medication: Close to 6,800 prescription 
medications and countless over-the-counter drugs are 
available in the United States. Each year, in the United 
States alone, 7,000 to 9,000 people die as a result of a 
medication error. The total cost of looking after patients 
with medication-associated errors exceeds $40 billion each 
year. Typical errors include the healthcare provider writing 
the wrong medication, wrong route or dose, or the wrong 
frequency. These ordering errors account for almost 50% 
of medication errors. It is obvious that medication errors 
are a pervasive problem, which is preventable. Data show 
that nurses and pharmacists identify anywhere from 30% 
to 70% of medication-ordering errors (Bhimji et.al., 2018) 
h) Complexity of treatment: The complexity of treatment 
regimens is another frequently cited barrier that can be 
reframed as “the physicians prescribed too complex a 
treatment regimen.” Adherence is best in patients who 
were prescribed 1 medication rather than multiple 
medications. Higher frequency of dosing also reduces 
adherence. While there may be reasons to avoid 
prescribing combination products (e.g., if they are costly), 
the potential to improve adherence and outcomes by 
reducing the number of medications and frequency of 
dosing should not be ignored (Devine et.al, 2018 and 
Kleinsinger et.al, 2018). 
i) Taste of Medication: Approximately 4%of 4 billion 
medications dispensed in the United States are flavored 
liquid medications. This means that approximately 160 
million liquid prescriptions per year are candidates for 
custom medication flavoring. About 85% of the 
interviewed subjects in the intercept survey said that the 
taste of liquid medicine is v very or somewhat important to 
them and to their child. Overall, 79% of children 
complained about bad tasting medication or taste that is 
“too yucky” to take. Seven out of t end (70%) mothers 
surveyed filled 4 or more prescriptions per year – with the 
average respondent filing 4.3 prescriptions per year for 
their children (Wertheimer AI and Wilson JM, 2014) 
 
3.3. Patient-Provider Interaction 
These observations are equally important with respect to the 
interaction between the pharmacist and the patient. The 
following factors are among those that could influence 
compliance adversely if inadequate attention is given to the 
scope and quality of the interaction with the patient. 
a) Failure to Comprehend Importance of Therapy: Patients 
have fewer idea and least interest about illness, therapy 
indicated and its benefit and impact of non-compliance. A 
cross-sectional study (2014-2015) in South Indian tertiary 
hospital reveals 17% were illiterates, 65% of them had lack 
of information about prescribed medications 45% patients 
were not aware of the side effects of the prescribed 
medication, more than 70% patients were not aware of 
what happens on missing medications regularly, nearly 
65% and 60% of patients were not performing exercise and 
not following advice on diet respectively (Divya et.al., 
2015). 
b) Poor Understanding of the Instruction: To help combat 
poor health literacy and its negative effect on medication 
adherence, a “shame-free” environment must be created. 
Possible solutions to poor patient literacy include providing 
the patient with pictorial and audiovisual educational 
material instead of written instructions (Brown et.al., 
2011) 
• In some cases, confusion arises and mistakenly 
medications are given in wrong rout (e.g., swallowing 
suppositories, installing eardrops for otitis media to 
mouth, IV given to IM). 
• A patient being prepared for Nitroglycerin patch or 
Pilocarpine Ocusert. Although he had understood the 
instructions to apply, no instruction had been 
provided regarding their removal. 
 
4. Non-compliance Detection--Current detection methods 
include indirect measures, such as self-report, interview, 
therapeutic outcome, pill count, change in the weight of 
metered-dose inhaler canisters, medication-refill rate, 
insurance prescription claims databases, and 
computerized compliance monitors, and direct measures, 
such as biological markers, tracer compounds, and assay of 
body fluids. In general, the direct methods of detection 
have a higher sensitivity and specificity than the indirect 
methods. However, all of these methods have their 
limitations. To help overcome limitations of the 
assessment methods and to provide corroborative 
information, it is recommended that at least two different 
detection methods be used to measure compliance. 
4.1. Indirect Methods: Self-reports and interviews with 
patients are the most common and simplest methods of 
attempting to determine compliance with therapy. Pill 
counts are another detection method used to measure 
compliance and frequently are used in clinical drug studies. 
A patient’s compliance with a medication regimen can be 
assessed by the difference between the number of dosage 
units initially dispensed and the number remaining in the 
container on a return visit or during an unscheduled home 
visit. However, pill dumping (i.e., attempts by patients to 
misrepresent their compliance by discarding medication) is 
common, and several studies have shown that return 
counts grossly overestimate actual compliance rate. 
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4.2. Direct Methods: Biological markers and tracer compounds 
indicate patient compliance over an extended period. For 
example, measurement of glycosylated hemoglobin in 
patients with diabetes mellitus gives an objective 
assessment of metabolic control during the preceding 3-
month period. Tracer compounds—small amounts of 
agents with long half-lives such as phenobarbital—have 
been added to drugs in some studies and measured in 
biological fluids as pharmacological indicators of 
compliance (Hussar, 2006; Bond et.al., 1991; Liu et.al., 
2010) 
 
5. Improving Compliance 
Pharmacists have a particularly valuable opportunity to 
encourage compliance since their advice accompanies the 
actual dispensing of the medication, and they usually are the 
last health professional to see the patient prior to the time the 
medication is to be used. 
a) Identification of Risk Factors--These factors should be 
considered in planning the patient’s therapy so that the 
simplest regimen that is, to the extent possible, compatible 
with the patient’s normal activities can be developed. 
b) Development of Treatment Plan--The more complex the 
treatment regimen, the greater is the risk of 
noncompliance, and this must be recognized in the 
development of the treatment plan. Respecting each 
patient's autonomy, drawing out ambivalence about 
change, evoking change talk, and allowing the patient to 
develop and/or own the treatment plan greatly improve 
the odds of achieving positive clinical outcomes 
(Butterworth, 2008) 
c) Patient Education--One of the findings of the report of the 
Office of the Inspector General is “education is the best 
way to improve compliance.” Complex terms and 
unnecessary jargon are never appreciated by any patient. 
Patient should repeat the instructions for their better 
understanding and memorization and also should be 
encouraged to ask questions. Further, communication that 
ascertains patients’ needs, perspectives and values is also 
considered effective, as it a key feature of patient-centered 
care (Braaf et.al, 2018). 
d) Oral communication/counseling—Oral communication is 
the most effective patient education tool. It is most 
effective when privacy assured and free of distraction. 
e) Written communication—Many pharmacists provide 
patients with medication instruction PPIs. The provision of 
supplementary PPIs appears to be most effective in 
improving compliance with short-term therapeutic 
regimens (e.g., antibiotic therapy). For drugs used on a 
long-term basis, written information as plays an important 
role for patient compliance (Bosworth et.al., 2011 and 
Mazzullo, 1978) 
f) Audio-visual materials— The use of audio-visual aids may 
be particularly valuable in certain situations because 
patients may get a better picture of the illness or how their 
medication acts or is to be administered (e.g., the 
administration of insulin, the use of a metered-dose 
inhaler). The introduction of a video can reduce failure of 
adherence to safety-critical tasks and contribute to patient 
safety (Pratt et.al., 2017 and Kandler et.al., 2016) 
g) Controlled therapy—It has been proposed that 
hospitalized patients be given the responsibility for self- 
medication prior to discharge. Usually, patients go from a 
complete dependence on others for the administration of 
their medication while hospitalized to a situation in which 
they are given the full responsibility when discharged, 
often with the assumption that they know about their 
drugs because they were taking them in the hospital. The 
suggested arrangement would permit patients to start 
using the medications on their own before discharge, so 
that health-care professionals can more directly identify 
problems or situations that might undermine compliance, 
and answer patient questions (Waring et.al, 2014 and 
Reinhard et.al, 2008). 
h) Patient Motivation-- Motivation is the driving force 
underlying the wish to change behavior. HCPs reported 
that EMMA supported patient-centered consultations in 
adults with type 2 diabetes by facilitating dialogue, 
reflection, and patient activity. The use of tools elicited 
patients’ perspectives and facilitated patient participation 
and shared decision-making. After 2 months, nearly 60% 
participants stated that they followed the goal and plan to 
a high or very high extent (Varming et.al, 2015). 
 
6. Compliance Aids 
6.1. Labeling: The importance of the accuracy and specificity of 
the information on the label of the prescription container 
has been noted. Auxiliary labels that provide additional 
information regarding the use, precautions, and/or storage 
of the medication also will contribute to the attainment of 
compliance. The inclusion of pictograms in labeling and 
patient information leaflets has been demonstrated to 
have a positive effect in the acquisition and understanding 
of information regarding medications prescribed for 
patients with limited literacy skills. 
6.2. Special Medication Calendars and Drug Reminder Charts: 
Various forms, such as medication calendars, have been 
developed and are designed to assist patients in self-
administering drugs. In addition to their use in helping 
patients understand which medication to take and when to 
take it, the forms on which patients are to check the 
appropriate area for each dose of medication they take, 
can be evaluated by the pharmacist or physician when the 
patients return for more medication or have their next 
appointment. An automatically generated reminder chart 
is a practical and cost- effective aid to compliance (Boeni 
et.al., 2014 and Saghaeiannejad-Isfahani et.al., 2017) 
6.3. Special Medication Containers, Caps and Systems: 
Specially designed caps for prescription containers also 
have been developed to facilitate compliance, and include 
features such as a digital timepiece that displays the time 
and day on which the last dose of medication was taken, 
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and an alarm and flashing light when it is time to take the 
next dose. Containers/caps that contain all or some of 
these features include The Prescript Time Cap, The Pill 
Timer, and Remind Cap Closures. The use of 
microelectronic medication monitors, MEMS in the caps of 
prescription containers found to be increase adherence 
94% in patients taking anti-hypertensives (Checchi et.al, 
2014). For patients with vision impairment or who 
otherwise have difficulty reading information on 
prescription labels, products such as Talking Rx 
(MaxiAIDS.com), Scrip Talk (En-Vision America®, 2011), and 
Aloud Talking Prescription Labels have been developed to 
play a prerecorded message when activated. Instructions 
for using the medication are recorded in a small electronic 
unit or microchip that is attached to the bottom of the 
container or embedded in a label. 
 
 
 
 
 
 
 
 
 
Figure: (1) Medrol Dosepak (2) Talking Rx (3) Medicine-On-Time 
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6.4. Compliance Packaging: A compliance package is a 
prepackaged unit that provides one treatment cycle of the 
medication to the patient in a ready-to-use package, and 
a comprehensive review of the use of such packaging as a 
patient education tool has been published.  
 This type of packaging usually is based on blister 
packaging using unit-of-use dosing and is designed to 
serve as a patient-education tool for health 
professionals and to make it easier for patients to 
understand and remember to take their medications 
correctly at home. Specially designed packaging for 
oral contraceptives was one of the first initiatives of 
this type and has been valuable in increasing patient 
understanding of how these agents are to be taken. 
 Special packages of certain corticosteroids (eg. 
Medrol Dosepak) also have been designed to facilitate 
the use of steroids in dosage regimens that may be 
difficult to understand or remember (Baptist Health, 
2018) 
 The Medicine-On-Time system is an example of a 
packaging system that provides unit-of-use dosing 
with specific labeling in a plastic card that is set up like 
a calendar. In addition to simplifying the use of 
medications for patients who self-administer their 
medications, these systems also have been very 
useful in the distribution and administration of 
medications in assisted living and other patient-care 
facilities (Bouvier, 2012). 
 A possible negative effect of drug packaging on 
patient compliance is seen with the use of the child-
resistant containers. Some patients, particularly the 
elderly and those with conditions like arthritis, 
asthma and Parkinsonism, have difficulty opening 
some of these containers and may not persist in their 
efforts to do so. There also may be difficulty opening 
some foil-packed drugs. Pharmacists should be alert 
to problems of this type and, when appropriate, 
suggest use of standard containers or caps (Ozturk 
et.al., 2016; National Research Council, 2010; New 
medical devices 2014) 
 
6.5. Dosage Forms: New dosage forms of certain drugs also 
have been developed, in large part in recognition of 
problems of noncompliance. For example, the 
development of longer- acting, controlled-release dosage 
forms of numerous medications (egg, calcium channel 
blocking agents) has permitted less frequent 
administration of these agents, which facilitates 
compliance. The use of transdermal delivery systems 
permits less-frequent administration of the drugs (egg, 
nitroglycerin, fentanyl) given by this route (Hussar, 2006). 
 
 
 
 
 
6.6. Monitoring Therapy 
a) Self-Monitoring: Patients should be apprised of the 
importance of monitoring their own treatment 
regimen and, in some situations, the response 
parameters.  
b) Pharmacist Monitoring: Since pharmacists and 
pharmacy staff frequently interact with their 
patients and establish strong pharmacist-to-patient 
relationships, they are uniquely positioned to 
address their patient’s medication concerns and 
help improve adherence (Taitel et.al, 2017). The 
pharmacist’s role in minimizing noncompliance does 
not end when the prescription is dispensed. 
Pharmacist follow-up with telephoned or mailed 
refill reminders has been found to increase 
compliance. One approach in which both health 
professionals and patients have collaborated 
effectively in reviewing/monitoring the use of 
medication has been the brown bag program 
(Willeboordse et.al, 2014 and Köberlein-Neu et.al, 
2016). The Administration on Aging and NCPIE have 
encouraged older consumers to put all their 
medicines in a bag and take them to their health 
professional for a personalized medicine review 
(Mohiuddin , 2018). 
c) DOT: A method of drug administration in which a 
health care professional watches as a person takes 
each dose of a medication. Directly observed 
therapy (DOT) is used to ensure the person receives 
and takes all medications as prescribed and to 
monitor response to treatment. With DOT, a patient 
meets with a health care worker every day or several 
times a week. The health care worker also asks the 
patient about any problems or side effects with the 
medication. DOT should be done at a time and place 
that is convenient for the patient. DOT is widely used 
to manage tuberculosis (TB) disease. In HIV 
treatment, DOT is sometimes called directly 
administered antiretroviral therapy (DAART) (Lucas 
et.al, 2002; Garvie et.al, 1008; Hart et.al, 2010; Write 
et.al, 2015; Moonan et.al, 2011). 
 
“No single strategy or programmatic focus showed 
any clear advantage compared with another. 
Comprehensive interventions combining cognitive, 
behavioral, and affective components were more 
effective than single-focus interventions.” (Roter 
et.al., 1998; Sabate, 2003; Agabna, 2014) 
 
7. Role of Pharmacist in Patient Compliance 
Pharmacists’ involvement in health management is very 
crucial. They can 
 Suggest medical staff on proper selection of drugs.   
 Plan, monitor and evaluate drug programs to improve 
health and reduce health inequalities. 
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 Ensure that medicines are managed safely and 
effectively so that they are appropriate for the age, 
sex, body weight and clinical status of the patient  
 Not only dispense medications but also counsels’ 
patients regarding general health topics such as diet, 
exercise, stress management, OTC medications etc.  
 Provide specialized services to help patients with 
diabetes, asthma, smoking cessation, drug addiction, 
and patients with high blood pressure.  
 Can prevent drug interaction, counsel patient 
regarding the disease and medication e.g. providing 
information, advice and assistance about medication 
and therapy due to their access of interpersonal 
communication. 
 Clarify and verify instruction during patient 
counseling  
 Establish protocols, set order, monitor medication 
profile, support and facilitate patient/drug entry 
during prescribing 
 Organize drug storage and shelving, use of clinical 
information and clear instruction to nurse patients 
during dispensing 
 Follow up diagnosis, screening and daily review of 
drug profiles (Usherwood et.al., 2017; Amir et.al., 
2018; Jimmy et.al., 2011; Lemay et.al., 2018; Erku 
et.al., 2017; Ensing et.al., 2018; Fisher et.al., 1992) 
 
8. Benefits of patient compliance 
When patients experience chronic or acute episodes, many 
treatment options require patients to partake in lifestyle 
changes in order to address the root cause of their illness. The 
improvement of compliance will result in a situation in which 
all parties benefit. Most importantly, patients benefit from the 
enhancement of the efficacy and safety of their drug therapy. 
Pharmacists benefit because there is an increased recognition 
and respect for the value of the advice and service that they 
provide. Pharmaceutical manufacturers benefit from the 
favorable recognition that accompanies the effective and safe 
use of their drugs as well as from the increased sales resulting 
from the larger number of prescriptions being dispensed. 
Finally, society and the health care system benefit as a result 
of fewer problems associated with noncompliance. Although 
an increase in compliance will result in more prescriptions 
being dispensed and a higher level of expenditures for 
prescription medications, this increase in costs will be more 
than offset by a reduction in costs (eg, physician visits, 
hospitalizations) attributable to problems due to 
noncompliance (Suri et.al., 2017; Stefanacci et.al., 2013; 
Mardon, 2018; Foster et.al. 2010) 
 
Conclusion 
After decades of compliance research, very little consistent 
information is available, except that people do not take their 
medications as prescribed. Many have argued that much of the 
existing compliance literature also lacks conceptual rigor. 
Although we know that people do not take their medications 
consistently, we do not know specifically why they have done 
so. One reason for this lack of understanding is that 
compliance research has been dominated by the perspective 
of the health professional. Efforts toward improving patient 
compliance in medication focus on either identifying trends in 
patient features or studying changes through an intervention. 
Numerous factors may influence compliance among which 
patient's characteristics, disease peculiarities, drug treatment 
modalities, physician's attitudes and health system 
organization. The consequences of non-compliance to drug 
therapy may not only be harmful for patient's health, but could 
also negatively impact the financial cost of public health 
services. Thus, all efforts should be focused to improve drug 
compliance, if possible, by targeting all causes responsible for 
poor adherence to medications. 
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